Skip to content
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login

HIV Crisis: Impact of US Aid Cuts on Treatment

The HIV crisis deepens in South Africa as US aid cuts threaten vital health services and increase infection rates.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

HIV Funding Cuts and Their Impact on South Africa

HIV funding cuts threaten South Africa's progress in fighting the epidemic, with potential for thousands of new infections.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

“Close the Gap” HIV campaign targets 1.1m more on treatment

The campaign aims to provide treatment for an additional 1.1 million people living with HIV by the end of 2025. However, cuts to funding threaten this goal.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Global fund affirms commitment to lenacapavir rollout

The Global Fund for HIV, TB, and Malaria reaffirms its commitment to introducing the twice-yearly HIV prevention jab, lenacapavir, in underprivileged countries.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Trump’s USAID cuts threaten SA’s HIV/AIDS progress

The Trump administration's abrupt termination of USAID grants has jeopardised SA’s fight against HIV/AIDS, threatening health services and thousands of jobs.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Lenacapavir injection: The new frontier in HIV prevention

Despite its promise, access to Lenacapavir, a revolutionary HIV prevention injection which stops 100% of new HIV infections in women and girls, is restricted.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
← Previous